Bio-Rad Laboratories (BIO) Operating Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Operating Margin of 5.76% for Q1 2026, up 171.0% year-over-year from 2.13% in Q1 2025, and up 133.58% on a QoQ basis from 17.15% in Q4 2025.
Bio-Rad Laboratories (BIO) has 18 years of Operating Margin data on file, last reported at 5.76% in Q1 2026.
- Quarterly Operating Margin rose 171.0% year-over-year to 5.76% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.22% (down 754.0% YoY) and the FY2025 annual result came in at 1.83%, down 865.0% from the prior year.
- Operating Margin rose to 5.76% in Q1 2026 per BIO's latest filing, from 17.15% in the prior quarter.
- Across five years, Operating Margin topped out at 20.91% in Q1 2022 and bottomed at 17.15% in Q4 2025.
- The 5-year median for Operating Margin is 11.83% (2025), against an average of 10.35%.
- The widest annual swing landed in 2022, when Operating Margin surged 703 bps; it then slumped 2589 bps in 2025.
- Tracing BIO's Operating Margin over 5 years: stood at 16.25% in 2022, then slipped by 14 bps to 13.99% in 2023, then sank by 38 bps to 8.73% in 2024, then sank by 296 bps to 17.15% in 2025, then surged by 134 bps to 5.76% in 2026.
- Per Business Quant, the three latest BIO Operating Margin figures stand at 5.76% (Q1 2026), 17.15% (Q4 2025), and 10.0% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | 5.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.76% |
| Dec 31, 2025 | -17.15% |
| Sep 30, 2025 | 10.00% |
| Jun 30, 2025 | 11.83% |
| Mar 31, 2025 | 4.05% |
| Dec 31, 2024 | 8.73% |
| Sep 30, 2024 | 9.93% |
| Jun 30, 2024 | 15.90% |
| Mar 31, 2024 | 7.30% |
| Dec 31, 2023 | 13.99% |
| Sep 30, 2023 | 14.39% |
| Jun 30, 2023 | 13.16% |
| Mar 31, 2023 | 9.15% |
| Dec 31, 2022 | 16.25% |
| Sep 30, 2022 | 13.90% |
| Jun 30, 2022 | 17.78% |
| Mar 31, 2022 | 20.91% |
| Dec 31, 2021 | 16.09% |
| Sep 30, 2021 | 20.99% |
| Jun 30, 2021 | 17.43% |
| Mar 31, 2021 | 13.88% |
| Dec 31, 2020 | 23.50% |
| Sep 30, 2020 | 16.93% |
| Jun 30, 2020 | 9.64% |
| Mar 31, 2020 | 13.01% |
| Dec 31, 2019 | 9.48% |
| Sep 30, 2019 | 10.25% |
| Jun 30, 2019 | 9.85% |
| Mar 31, 2019 | 10.22% |
| Dec 31, 2018 | -36.81% |
| Sep 30, 2018 | 6.65% |
| Jun 30, 2018 | 7.60% |
| Mar 31, 2018 | 7.91% |
| Dec 31, 2017 | 7.39% |
| Sep 30, 2017 | 7.26% |
| Jun 30, 2017 | -0.34% |
| Mar 31, 2017 | 5.24% |
| Dec 31, 2016 | -4.93% |
| Sep 30, 2016 | 4.46% |
| Jun 30, 2016 | 5.21% |
| Mar 31, 2016 | 4.29% |
| Dec 31, 2015 | 10.42% |
| Sep 30, 2015 | 6.95% |
| Jun 30, 2015 | 7.94% |
| Mar 31, 2015 | 7.27% |
| Dec 31, 2014 | 8.46% |
| Sep 30, 2014 | 6.26% |
| Jun 30, 2014 | 8.51% |
| Mar 31, 2014 | 4.02% |
| Dec 31, 2013 | 8.68% |
| Sep 30, 2013 | 5.75% |
| Jun 30, 2013 | 10.08% |
| Mar 31, 2013 | 7.03% |
| Sep 30, 2012 | 13.20% |
| Jun 30, 2012 | 14.36% |
| Mar 31, 2012 | 11.18% |
| Dec 31, 2011 | 17.45% |
| Sep 30, 2011 | 14.31% |
| Jun 30, 2011 | 13.07% |
| Mar 31, 2011 | 13.84% |
| Dec 31, 2010 | 14.57% |
| Sep 30, 2010 | 15.86% |
| Jun 30, 2010 | 14.58% |
| Mar 31, 2010 | 13.92% |
| Dec 31, 2009 | 11.37% |
| Sep 30, 2009 | 14.61% |
| Jun 30, 2009 | 13.08% |